In 2025, the average American working full-time earns about $66,622 a year. Now consider this: the average annual cost of specialty drugs is $84,000 a year.
And no, we’re not talking about rare outliers. Specialty drugs, once niche, now dominate the pharmaceutical pipeline. They treat conditions like cancer, rheumatoid arthritis, Crohn’s disease, and multiple sclerosis. Only 1–2% of employees may need them, but those claims can drive up to 80% of your pharmacy costs.
Virtual consultations with quality clinical laboratories offer a convenient, cost-effective, and efficient way for patients to access healthcare and diagnostic services remotely. By leveraging telemedicine platforms, patients can consult with healthcare professionals, discuss symptoms, and receive expert guidance without the need for in-person visits. Clinical laboratories play a vital role by providing accurate and timely test results, enabling doctors to make informed decisions regarding diagnosis and treatment.
In 2025, the average American working full-time earns about $66,622 a year.
Now consider this: the average annual cost of specialty drugs is $84,000 a year.
That’s right. For a self-insured employer, it is now entirely possible – and increasingly common – to pay more for a single employee’s medication than for their actual salary.
And no, we’re not talking about rare outliers. Specialty drugs, once niche, now dominate the pharmaceutical pipeline. They treat conditions like cancer, rheumatoid arthritis, Crohn’s disease, and multiple sclerosis. Only 1–2% of employees may need them, but those claims can drive up to 80% of your pharmacy costs.
Premiums rise. Deductibles swell. Out-of-pocket burdens grow heavier for everyone.
This isn’t about denying care. It’s about asking why the system tolerates such wildly inflated pricing, and why the default model often forces employers to foot the bill without options, guardrails, or visibility.
Because here’s the truth: the medicine didn’t have to cost that much.
The price didn’t climb because of innovation alone. It climbed because of fractured distribution, misaligned incentives, and legacy benefit structures that haven’t evolved as fast as the drug market has.
That’s where Aphora Health comes in.
By bypassing bloated pricing models, validating clinical appropriateness, and sourcing specialty drugs through optimized channels, Aphora Health routinely helps employers save up to 70%, without compromising care or outcomes. It’s a strategy, not a shortcut.
If your benefits budget is treating medicine like a six-figure executive, it might be time to rethink your plan.
A drug shouldn’t out earn your employees. Let’s bring pharmacy costs back to earth, together. Visit us at our website to find out how you can save.
.png)
.svg)
.svg)
